Clinical trial
The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study
NCT01622777
Study timeline
Study start (unknown)2010-02-01Date precision: month
Registry last updated2012-06-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetic Polyneuropathyunresolved
Interventions
RosuvastatinDRUG · verified · RxNorm: rosuvastatin
PlaceboDRUG
Sponsors & collaborators
Alejandra Guillermina Miranda Diazlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01622777 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.